Lasers News

MIAMI BEACH, Fla. — Some of the latest developments and uses in laser technology were reviewed at the American Academy of Dermatology Annual Meeting.

Legal cases related to cutaneous laser surgery are increasing, with indemnity payments exceeding the average amount previously reported for all medical specialties, according to recent study results.

Ablative fractional resurfacing safely and effectively treated textural skin changes resulting from involuted infantile hemangiomas, according to study results.

A fractional microneedle radiofrequency device and a CO2 fractional laser system performed equally well in treating facial acne vulgaris, while microneedle treatment reduced recovery time, according to study results.

A low-energy, nonablative fractionated 1440-nm laser safely and effectively reduced patients’ detectable facial pores and improved skin appearance, according to study results.

Fractionated nonablative thulium laser therapy was effective and safe in treating patients with facial actinic keratoses, according to study results.

The FDA has given 510(k) clearance to Cynosure to market its picosecond laser device for the removal of tattoos and benign pigmented lesions, the company announced.

Fractional diode laser with radiofrequency therapy followed by fractional radiofrequency to treat acne scars in an Asian population resulted in modest improvement and low post-inflammatory hyperpigmentation, according to study results.

Patients with mature burn scars treated with a fractional carbon dioxide laser experienced improved scar appearance and collagen architecture, according to study results.

The FDA has approved a supplemental New Drug Application for a 7% lidocaine/7% tetracaine cream as a topical local anesthetic to minimize pain during dermatologic procedures, according to its Canadian manufacturer.